tiprankstipranks
Trending News
More News >
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Income Statement

Compare
102 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q1 2025), Mangoceuticals, Inc.'s total revenue was $109.31K, a decrease of -48.95% from the same quarter last year. In Q1, Mangoceuticals, Inc.'s net income was $-4.84M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 615.87K$ 731.49K$ 8.94K$ 0.00
Gross Profit
$ 379.96K$ 431.50K$ 4.85K$ 0.00
Operating Expenses
$ 8.35M$ 9.65M$ 2.00M$ 17.52K
Depreciation and Amortization
$ 721.53K$ 24.89K$ 3.86K$ 70.08K
EBITDA
$ -7.96M$ -9.19M$ -1.99M$ 52.56K
Operating Income
$ -7.97M$ -9.22M$ -1.99M$ -17.52K
Other Income/Expenses
$ -735.00K$ 6.47K$ -6.47K$ -724.00
Pretax Income
$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Net Income
$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Per Share Metrics
Basic EPS
$ -4.84$ -8.58$ -1.96$ -10.22K
Diluted EPS
$ -4.84$ -8.58$ -1.96$ -10.22K
Weighted Average Shares Outstanding
1.98M 1.07M 1.02M 533.33K
Weighted Average Shares Outstanding (Diluted)
1.98M 1.07M 1.02M 533.33K
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis